{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:05:16Z","timestamp":1778097916585,"version":"3.51.4"},"reference-count":156,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.eimc.2011.01.008","type":"journal-article","created":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T10:54:46Z","timestamp":1308048886000},"page":"345-361","source":"Crossref","is-referenced-by-count":58,"title":["Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC). Actualizaci\u00f3n 2011"],"prefix":"10.1016","volume":"29","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ruiz-Camps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Mart\u00edn-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"\u00c1lvarez-Lerma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crist\u00f3bal","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Ruiz-Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2011.01.008_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.eimc.2011.01.008_bib0010","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol."},{"issue":"Suppl 2","key":"10.1016\/j.eimc.2011.01.008_bib0015","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0924-8579(08)70006-2","article-title":"Epidemiology of candidemia in intensive care units","volume":"32","author":"Bouza","year":"2008","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.eimc.2011.01.008_bib0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption ofprophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0025","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer."},{"key":"10.1016\/j.eimc.2011.01.008_bib0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2141.2007.06812.x","article-title":"Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients","volume":"139","author":"Barnes","year":"2007","journal-title":"Br J Haematol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0035","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.ejca.2008.07.008","article-title":"The First European Conference on Infections in Leukaemia -ECIL1: a current perspective","volume":"44","author":"Meunier","year":"2008","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.eimc.2011.01.008_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","article-title":"Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"88","author":"B\u00f6hme","year":"2009","journal-title":"Ann Hematol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0050","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF01726360","article-title":"Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group","volume":"16","author":"Phillips","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0060","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0065","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","article-title":"Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2011.01.008_bib0070","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis. Caspofungin Invasive Candidiasis Study Group","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0075","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0080","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia andinvasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2011.01.008_bib0085","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0090","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0095","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B: time for a new \u201cgold standard\u201d","volume":"37","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2011.01.008_bib0110","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1469-0691.2007.01758.x","article-title":"Impact of early central venous catheter removal on outcome in patients with candidaemia","volume":"13","author":"Rodr\u00edguez","year":"2007","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.eimc.2011.01.008_bib0115","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9343(91)90006-J","article-title":"Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy","volume":"91","author":"Anaissie","year":"1991","journal-title":"Am J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9343(91)90005-I","article-title":"Hepatosplenic candidiasis: successful treatment with fluconazole","volume":"91","author":"Kauffman","year":"1991","journal-title":"Am J Med. 1"},{"key":"10.1016\/j.eimc.2011.01.008_bib0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF01372718","article-title":"Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report","volume":"119","author":"Gokhale","year":"1993","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0135","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/343748","article-title":"Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B","volume":"35","author":"Sor\u00e0","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2011.01.008_bib0140","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/14656566.7.3.297","article-title":"Fungal infections in solid organ transplantation","volume":"7","author":"Marik","year":"2006","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0155","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.00990-07","article-title":"Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis","volume":"52","author":"Kontoyiannis","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0160","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/511438","article-title":"Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality","volume":"195","author":"Singh","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/AAC.44.3.739-746.2000","article-title":"Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991\/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans","volume":"44","author":"Del Poeta","year":"2000","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0175","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/AAC.01031-09","article-title":"Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species","volume":"53","author":"Mann","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0180","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1600-6143.2007.02089.x","article-title":"Antifungal management practices in liver transplant recipients","volume":"8","author":"Singh","year":"2008","journal-title":"Am J Transplant."},{"key":"10.1016\/j.eimc.2011.01.008_bib0185","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-6143.2005.01176.x","article-title":"Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study","volume":"6","author":"Pappas","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1016\/j.eimc.2011.01.008_bib0190","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/TP.0b013e3181932e76","article-title":"Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients","volume":"87","author":"Fortun","year":"2009","journal-title":"Transplantation."},{"key":"10.1016\/j.eimc.2011.01.008_bib0195","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","article-title":"Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation."},{"issue":"Suppl 6","key":"10.1016\/j.eimc.2011.01.008_bib0200","doi-asserted-by":"crossref","first-page":"S409","DOI":"10.1086\/429337","article-title":"Successful use of amphotericin B lipid complex in the treatment of cryptococcosis","volume":"40","author":"Baddour","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0205","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0149-2918(03)80125-X","article-title":"A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations","volume":"25","author":"Barrett","year":"2003","journal-title":"Clin Ther."},{"key":"10.1016\/j.eimc.2011.01.008_bib0210","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/647948","article-title":"Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis","volume":"49","author":"Sun","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","article-title":"Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis","volume":"50","author":"Schwarz","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0220","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2011.01.008_bib0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0235","doi-asserted-by":"crossref","first-page":"e2870","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis","volume":"3","author":"Dromer","year":"2008","journal-title":"PLoS One."},{"key":"10.1016\/j.eimc.2011.01.008_bib0240","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/AAC.35.4.726","article-title":"Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis","volume":"35","author":"Allendoerfer","year":"1991","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0245","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1590\/S0036-46651994000600013","article-title":"Flucytosine+fluconazole association in the treatment of a murine experimental model of cryptococcosis","volume":"36","author":"Bava","year":"1994","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"10.1016\/j.eimc.2011.01.008_bib0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures","volume":"23","author":"Bicanic","year":"2009","journal-title":"AIDS."},{"key":"10.1016\/j.eimc.2011.01.008_bib0255","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1086\/340525","article-title":"Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus","volume":"34","author":"Liliang","year":"2002","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/313603","article-title":"Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups","volume":"30","author":"Graybill","year":"2000","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/j.1875-9114.1990.tb02588.x","article-title":"Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis","volume":"10","author":"Chin","year":"1990","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.eimc.2011.01.008_bib0270","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1086\/523576","article-title":"Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent","volume":"45","author":"Nagappan","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0275","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1179\/joc.2009.21.1.108","article-title":"Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant","volume":"21","author":"Bandettini","year":"2009","journal-title":"J Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0280","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/598936","article-title":"Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0285","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0290","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/01.tp.0000180530.17683.02","article-title":"Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome","volume":"80","author":"Singh","year":"2005","journal-title":"Transplantation."},{"key":"10.1016\/j.eimc.2011.01.008_bib0295","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00134-009-1431-6","article-title":"Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?","volume":"35","author":"P\u00e9rez-Parra","year":"2009","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0300","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0305","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/clinids\/20.6.1526","article-title":"Epidemiology of nosocomial fungal infections, with emphasis on Candida species","volume":"20","author":"Jarvis","year":"1995","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0310","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International Study of the Prevalence and Outcomes of Infection in Intensive Care Units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2011.01.008_bib0315","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0320","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10096-008-0618-z","article-title":"Fungal colonization and\/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study","volume":"28","author":"Le\u00f3n","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0325","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Le\u00f3n","year":"2009","journal-title":"Crit Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0330","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/CCM.0b013e31819efac0","article-title":"Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)","volume":"37","author":"Leroy","year":"2009","journal-title":"Crit Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0335","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/cc7964","article-title":"Determinants of mortality in non-neutropenic ICU patients with candidaemia","volume":"13","author":"Marriott","year":"2009","journal-title":"Critical Care."},{"key":"10.1016\/j.eimc.2011.01.008_bib0340","doi-asserted-by":"crossref","first-page":"554.e1","DOI":"10.1016\/j.ijantimicag.2008.10.035","article-title":"Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units","volume":"33","author":"Holley","year":"2009","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.eimc.2011.01.008_bib0345","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00003246-199906000-00019","article-title":"Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients","volume":"27","author":"Eggimann","year":"1999","journal-title":"Crit Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0350","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg."},{"key":"10.1016\/j.eimc.2011.01.008_bib0355","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00134-002-1540-y","article-title":"Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination","volume":"28","author":"Garbino","year":"2002","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0360","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0365","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00134-005-2794-y","article-title":"Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis","volume":"31","author":"Cruciani","year":"2005","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0370","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jac\/dki491","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials","volume":"57","author":"Playford","year":"2006","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0375","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.CCM.0000208357.05675.C3","article-title":"Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials","volume":"34","author":"Vardakas","year":"2006","journal-title":"Crit Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0380","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg."},{"key":"10.1016\/j.eimc.2011.01.008_bib0385","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0390","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcrc.2006.11.004","article-title":"Invasive candidiasis treated in the intensive care unit: Observations from a randomized clinical trial","volume":"22","author":"DiNubile","year":"2007","journal-title":"J Crit Care."},{"key":"10.1016\/j.eimc.2011.01.008_bib0395","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jac\/dkq216","article-title":"A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients","volume":"65","author":"Hsu","year":"2010","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0400","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jac\/dkp495","article-title":"Candida spp. bloodstream infection: influence of antifungal treatment on outcome","volume":"65","author":"Ortega","year":"2010","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0405","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/JCM.44.2.529-535.2006","article-title":"Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy","volume":"44","author":"Magill","year":"2006","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s001340050286","article-title":"Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU","volume":"23","author":"Nolla-Salas","year":"1997","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.eimc.2011.01.008_bib0415","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0425","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jac\/dkm212","article-title":"Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections","volume":"60","author":"Parkins","year":"2007","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0430","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1542\/peds.2005-1996","article-title":"Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004","volume":"117","author":"Fridkin","year":"2006","journal-title":"Pediatrics."},{"issue":"2 Pt 1","key":"10.1016\/j.eimc.2011.01.008_bib0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0440","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00006454-200112000-00005","article-title":"Risk factors for Candida species colonization of neonatal intensive care unit patients","volume":"20","author":"Saiman","year":"2001","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0445","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00008480-200302000-00016","article-title":"Candida infections in the neonate","volume":"15","author":"Chapman","year":"2003","journal-title":"Curr Opin Pediatr."},{"key":"10.1016\/j.eimc.2011.01.008_bib0450","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/01.inf.0000202127.43695.06","article-title":"Candidemia in neonatal intensive care units: Barcelona","volume":"25","author":"Rodr\u00edguez","year":"2006","journal-title":"Spain. Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0455","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-2003-40008","article-title":"Neonatal invasive candidiasis: a prospective multicenter study of 118 cases","volume":"20","author":"L\u00f3pez Sastre","year":"2003","journal-title":"Am J Perinatol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0460","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/313973","article-title":"Candidal meningitis in neonates: a 10-year review","volume":"31","author":"Fern\u00e1ndez","year":"2000","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0465","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1542\/peds.2005-2677","article-title":"The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants","volume":"118","author":"Cotten","year":"2006","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0470","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.inf.0000226978.96218.e6","article-title":"Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth","volume":"25","author":"Kaufman","year":"2006","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0475","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0480","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0485","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1542\/peds.106.5.e63","article-title":"Should central venous catheters be removed as soon as candidemia is detected in neonates?","volume":"106","author":"Karlowicz","year":"2000","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0490","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00006454-200009000-00003","article-title":"Persistently positive cultures and outcome in invasive neonatal candidiasis","volume":"19","author":"Chapman","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0495","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.pcl.2005.02.009","article-title":"Antifungal agents in children","volume":"52","author":"Steinbach","year":"2005","journal-title":"Pediatr Clin North Am."},{"key":"10.1016\/j.eimc.2011.01.008_bib0500","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00148581-200709050-00004","article-title":"Antifungal agents in neonates: issues and recommendations","volume":"9","author":"Almirante","year":"2007","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.eimc.2011.01.008_bib0505","unstructured":"American Academy of Pediatrics. Candidiasis. En: Pickering, L.K., editor. Red Book: 2009 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2009.p.245-253."},{"key":"10.1016\/j.eimc.2011.01.008_bib0510","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0515","first-page":"194","article-title":"Amphotericin B dosage for disseminated candidiasis in premature infants","volume":"7","author":"Hall","year":"1987","journal-title":"J Perinatol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0520","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/155.4.766","article-title":"Pharmacokinetics of amphotericin B in infants and children","volume":"155","author":"Starke","year":"1987","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0525","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0022-3476(05)82674-5","article-title":"Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates","volume":"116","author":"Baley","year":"1990","journal-title":"J Pediatr."},{"key":"10.1016\/j.eimc.2011.01.008_bib0530","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00006454-199811000-00008","article-title":"Management of neonatal candidiasis. Neonatal Candidiasis Study Group","volume":"17","author":"Rowen","year":"1998","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0535","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00006454-199001000-00012","article-title":"Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates","volume":"9","author":"Butler","year":"1990","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0540","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.41.9.1944","article-title":"Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis","volume":"41","author":"Walsh","year":"1997","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0545","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0550","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00006454-199802000-00013","article-title":"Liposomal amphotericin B treatment for neonatal fungal infections","volume":"17","author":"Scarcella","year":"1998","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0555","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-003-0993-4","article-title":"High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates","volume":"22","author":"Juster-Reicher","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0560","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3476(05)81975-4","article-title":"Safety and pharmacokinetics of fluconazole in children with neoplastic diseases","volume":"120","author":"Lee","year":"1992","journal-title":"J Pediatr."},{"key":"10.1016\/j.eimc.2011.01.008_bib0565","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/clpt.1993.147","article-title":"Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life","volume":"54","author":"Saxen","year":"1993","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.eimc.2011.01.008_bib0570","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.1875-9114.1995.tb04331.x","article-title":"Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases","volume":"15","author":"Seay","year":"1995","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.eimc.2011.01.008_bib0575","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/AAC.00569-08","article-title":"Population pharmacokinetics of fluconazole in young infants","volume":"52","author":"Wade","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0580","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/INF.0b013e31819f1f50","article-title":"Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants","volume":"28","author":"Wade","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0585","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00006454-199612000-00011","article-title":"Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial","volume":"15","author":"Driessen","year":"1996","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0590","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jac\/dkg419","article-title":"Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations","volume":"52","author":"Linder","year":"2003","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0595","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1128\/AAC.49.12.5092-5098.2005","article-title":"Population pharmacokinetics of amphotericin B lipid complex in neonates","volume":"49","author":"W\u00fcrthwein","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0600","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.qco.0000185986.64759.9a","article-title":"New antifungal agents under development in children and neonates","volume":"18","author":"Steinbach","year":"2005","journal-title":"Curr Opin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0605","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/AAC.49.8.3317-3324.2005","article-title":"Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients","volume":"49","author":"Seibel","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0610","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.inf.0000245103.07614.e1","article-title":"The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants","volume":"25","author":"Heresi","year":"2006","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0615","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/AAC.50.2.632-638.2006","article-title":"Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections","volume":"50","author":"Benjamin","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0620","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":"Pharmacokinetics of an elevated dosage of micafungin in premature neonates","volume":"28","author":"Smith","year":"2009","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0625","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0630","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/clinids\/20.3.571","article-title":"Candidemia in a pediatric population","volume":"20","author":"Stamos","year":"1995","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0635","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1542\/peds.2008-2055","article-title":"Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients","volume":"123","author":"Blyth","year":"2009","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0640","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1439-0507.2007.01464.x","article-title":"Nosocomial candidaemia in children: results of a 9-year study","volume":"51","author":"Celebi","year":"2008","journal-title":"Mycoses."},{"key":"10.1016\/j.eimc.2011.01.008_bib0645","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/INF.0b013e31817eeee5","article-title":"Pediatric antifungal utilization: new drugs, new trends","volume":"27","author":"Prasad","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0650","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.2006-2931","article-title":"Antifungal therapy in children witn invasive fungal infections: a systematic review","volume":"119","author":"Blyth","year":"2007","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0655","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0660","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.00751-08","article-title":"Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies","volume":"53","author":"Karlsson","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0665","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/648679","article-title":"Voriconazole pharmacokinetics and pharmacodynamics in children","volume":"50","author":"Neeley","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0670","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e3181937fe0","article-title":"Caspofungin for the treatment of pediatric fungal infections","volume":"27","author":"Fisher","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0675","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.2008-1158","article-title":"A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0680","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0685","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.2006-2931","article-title":"Antifungal therapy in children with invasive fungal infections: a systematic review","volume":"119","author":"Blyth","year":"2007","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2011.01.008_bib0690","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01974618","article-title":"Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group","volume":"13","author":"Presterl","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0695","first-page":"203","article-title":"Treatment of candidal infections with fluconazole in neonates and infants","volume":"5","author":"Schwarze","year":"2000","journal-title":"Eur J Med Res."},{"key":"10.1016\/j.eimc.2011.01.008_bib0700","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.inf.0000145408.51526.0a","article-title":"Caspofungin therapy of neonates with invasive candidiasis","volume":"23","author":"Odio","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0705","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/01.inf.0000246844.42159.a0","article-title":"Efficacy and safety of caspofungin therapy in children with invasive fungal infections","volume":"25","author":"Merlin","year":"2006","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0710","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/INF.0b013e318067b4d1","article-title":"Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children","volume":"26","author":"Koo","year":"2007","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0715","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/adc.2007.118844","article-title":"Voriconazole plasma monitoring","volume":"93","author":"Pasqualotto","year":"2008","journal-title":"Arch Dis Child."},{"key":"10.1016\/j.eimc.2011.01.008_bib0720","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":"A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia","volume":"29","author":"Maertens","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0725","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00006454-199609000-00012","article-title":"Cryptococcosis in human immunodeficiency virus-infected children","volume":"15","author":"Gonzalez","year":"1996","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0730","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.inf.0000115639.43305.9b","article-title":"Mother-to-child transmission of cryptococcus neoformans","volume":"23","author":"Sirinavin","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0735","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1258\/0956462971920226","article-title":"Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis","volume":"8","author":"Manfredi","year":"1997","journal-title":"Int J STD AIDS."},{"key":"10.1016\/j.eimc.2011.01.008_bib0740","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.inf.0000153183.51258.b8","article-title":"Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections","volume":"24","author":"Wiley","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2011.01.008_bib0745","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0750","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0755","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a restropective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0760","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0732-8893(01)00215-2","article-title":"Trichosporon species infection in bone marrow transplanted patients","volume":"39","author":"Moretti-Branchini","year":"2001","journal-title":"Diagnost Microbiol Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0765","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1086\/505970","article-title":"Succesful treatment of breakthrough Trichosporon ashaii fungemia with voriconazole in a patient with acute myeloid leukemia","volume":"43","author":"Asada","year":"2006","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2011.01.008_bib0770","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1067\/mai.2003.1522","article-title":"Trichosporon pullulans infection in 2 patientes with chronic granulomatous disease: an emerging pathogen and review of the literature","volume":"111","author":"Moylett","year":"2003","journal-title":"J Allergy Clin Immnunol."},{"key":"10.1016\/j.eimc.2011.01.008_bib0775","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.00045-06","article-title":"Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis","volume":"50","author":"Serena","year":"2006","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2011.01.008_bib0780","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.mph.0000164865.70522.d7","article-title":"Fungemia due Trichosporon asahii in a neutropenic child refractary to amphoteriocin B. Clearance with voriconazole","volume":"27","author":"Antachopoulos","year":"2005","journal-title":"J Pediatr Hematol Oncol."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X11000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T14:40:10Z","timestamp":1712500810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X11000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0213005X11000280"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2011.01.008","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}